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INTRODUCTION 
 
Cancer or malignant tumor originates from abnormal growth of 
cells in the body. The proliferation of cells is uncontrolled and becomes 
to abnormal large size or tumors (except the leukemia). The cancer cells 
usually destroy normal cells or other healthy tissues in the process of 
invasion and metastasis and lead to death (1). Cancer is the third of 
leading causes of death in the world after cardiovascular and infectious 
diseases. The cancer incidence is varied in different areas of the world 
and its trend increases every year. The highest incidence rates are 
reported in North America, Australia, New Zealand, Europe, and Japan. 
Furthermore, the cancer incidence in male patient is higher than that in 
female patient (2). The colorectal cancer is the top five common 
worldwide of cancer incidence and most common form of malignancy in 
both Thai’s men and women (3-5).  
The treatments of cancer are conventional and novel therapy. 
Conventional therapies are surgery, radiotherapy and chemotherapy. 
Novel therapies are the biological therapies and more specific to tumor 
types or target tumor including: monoclonal antibodies, vaccines, gene 
therapy and small molecule signaling inhibitors. The kind of surgery 
varies depending on the type of cancer and the patients' physical fitness. 
This therapy is not generally an appropriate modality in some cancer, for 
example, lymphomas, leukemia and small cell lung cancer (6). In 
chemotherapy, drugs are designed to arrest the cell cycle of cancerous 
cells. However, their mode of action involves targeting rapidly dividing 
cells, thus they are known to cause severe side effects to rapidly dividing 
normal cells in the human body (1). Radiation is a conventional cancer 
treatment. Radiation therapy works by damaging the deoxyribonucleic 
acid (DNA) of the cancerous cells, but this may also damage the DNA 
of normal cells leading to adverse side effects (7). Since there is less 
toxicity and undesirable events of natural compounds constituents 
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presenting in herbal plants, the study of those on cancer has been 
augmented (8). 
 
Table 1 Major families of drugs used in cancer chemotherapy and novel 
therapy (4, 9) 
Chemotherapy drugs Novel anticancer 
drugs 
Alkylating agents Anti-metabolites Mitosis 
inhibitors 
DNA crosslinking 
agent 
     Nitrogen mustard 
     Chlorambucil 
     Melphalan 
     Cisplatin 
 
Pyrimidine analog 
     Cytarabine 
     Fluorouracil 
     Gemcitabine 
Purine analog 
     Thioguanine 
     Mercaptopurine 
Folic acid antagonist 
     Methotrexate 
Vinblastine 
Vincristine 
Paclitaxel 
(Taxol) 
Etoposide 
Topotecan 
Irinotecan 
 
Monoclonal antibody 
     Herceptin 
Tyrosine kinase 
inhibitors 
     Gefitinib 
     Gleevec 
Antisense 
oligonucleotide 
Matrix 
metalloproteinase 
inhibitor  
 
There are many reasons for the increased use of natural products. 
Since natural compounds are obtained from diverse sources. Plants are 
another natural source of anticancer drugs. Several anti-cancer drugs are 
discovered for current drugs, for example vincristine, vinblastine, 
ellipticine and taxol (paclitaxel). Phytomedicines are believed to have 
health benefits and still remain interested. Recently, the edible plant and 
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medicinal plant continue being a popular study which possesses a wide 
range of in vitro activities (10). M. oleifera has common name as 
drumstick. This plant is a member of Moringaceae family. It is a natural 
nutrition found in the tropical regions of the world, such as Indonesia, 
Philippines, Hawaii, Africa, and also Thailand (11, 12). 
In nutritional view, almost every part of plant has value for being 
food, for instance, leaves, fruits, flower and immature pods (13). In 
2010, Amaglo et al. determined the types and contents of components in 
the different parts of M. oleifera. Nutrients, the high content of crude 
proteins was found in the extract of leaves, flowers, pods and seeds and 
the highest amount was found in mature seeds extract. Moreover, it has 
been reported of highest crude fat in flowers and pods (14). On the other 
hand, Makkar and Becker studied that the extract of leaves, flowers, 
pods and seeds showed high crude fat values and the highest crude fat 
values detected from mature seeds (15). This variation possibly owing to 
various cultivation factors results in its components content (16). 
Additionally, M. oleifera has been documented retaining a high level of 
minerals (Ca, K and Mg) especially in leaves while mature pods and 
seeds have the high potassium and magnesium, respectively. Overall, the 
leaves of M. oleifera have value for dietary nutrients (14). 
In phytochemicals view, the amount of glucosinolates in each parts 
of M. oleifera was revealed. Glucosinolates were found in the leaves and 
seeds very high. The most of them is glucomoringin. M. oleifera consist 
of the complex of flavonoids (quercetin > kaempferol > isorhamnetin) 
including flavonoid glycosides (glucosides, rutinosides and 
malonylglucosides). Caffeoylquinic acid (chlorogenic acid), a phenolic 
acid was found in stem, leaves, flowers and leafstalk (14).  Nevertheless, 
the sample processing affects to lose some compounds and lose the 
content of compounds (14, 17). For example, the endogenous enzyme 
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during either tissue damage or rehydration process can cause losing of 
isothiocyanate and nitriles component. Previously, M. oleifera leaves 
have been reported that the content of flavonoids, multiflorin-B, 
apigenin-8-C-glucoside, quercetin-3-O-β-D-glucoside, quercetin-3-O-
acetyl glucoside, kaempferol-3-O-glucoside and kaempferol-3-O-acetyl 
glucoside, were lost in the 50% and 70% EtOH extracts of M. oleifera 
leaves, compared to the 90% EtOH extract (17). 
The leaves of M. oleifera are a potential source of vitamin C, 
calcium, β-carotene, fatty acid, mineral, potassium as well as essential 
amino acids (17). Thus, it was used as an alternative for growth 
stimulators in dairy cows (18-19). Moreover, it contains several 
antioxidant compounds, such as flavonoids, ascorbic acid, carotenoids 
and phenolics. M. oleifera leaves are abundant nutrients and antioxidants 
in which the components content is altered by some factors, such as 
harvest region, leaf age, preparation method and harvest season (20-26). 
The store of M. oleifera leaves (fresh, cooked or dried powder) for a 
long time without infrigidation or chilling, do not break their nutritional 
value. Additionally, the leaves are boiled three times that represent more 
systemic available iron than the uncooked leaves (27). These results are 
also observed in the dried powder of leaves. Both mature and tender 
leaves exhibit strong antioxidant activity against free radicals (27).   
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Table 2 Structures of previously reported in M. oleifera; a R1=-Glc, R2=H, R3=OH, b 
R1=  -Glc, R2=OH, R3=OH, c R1=-GlcMal, R2=H, R3=OH, d R1=-GlcMal, R2=OH, R3=OH (14). 
Chemical compound Structure 
Benzylgucosinolate (Glucotropaeolin) 
 
 
4-Hydroxybenzylglucosinolate (Sinalbin) 
 
 
4-O-(α-L-Rhamnopyranosyloxy)-benzylglucosinolate 
(Glucomoringin) 
 
4-(α-L-Rhamnopyranosyloxy)-benzylisothiocyanate 
 
 
Niazirin 
 
Niazimicin 
 
 
5-Caffeoylquinic acid (Chlorogenic acid) 
 
Kaempferol-3-O-Glucosidea 
Quercetin-3-O-Glucosideb 
Kaempferol-3-O-(6ʺ-Malonylglucoside)c 
Quercetin -3-O-(6ʺ-Malonylglucoside)d 
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In vitro study, leaves are reported to possess antimicrobial potential 
both bacterial (28) and fungal (29). According to Verma et al. (30), the 
effect of 50% ethanolic leaf extract of M. oleifera on ulcerogenesis were 
conducted. This study was represented the reduced total ulcerogenic 
effect in a dose-dependent. The extract decreases acid-pepsin secretion 
as well as exhibited ulcer protective properties (30). The study by Tende 
et al. showed that the hypoglycemic and anti-hyperglycemic activity of 
M. oleifera leaves may be resulted from presence of terpenoids, which 
appeared to be involved in the modulation of the β-cells and the 
sequential secernment of prefored insulin (31). Saliman also found that 
the ethanolic leaves extract was capable reducing hyperglycemia in 
streptozocin diabetic male rats (32). 
Furthermore, the M. oleifera leaves extract elicits anti-proliferation 
and apoptosis induction in human epidermal carcinoma cells and 
epithelial ovarian cancer cells (33, 10), and persuades the toxicity in 
pancreatic cancer cells (Panc-1) (34). In cancerous human lung cells 
(A549), Tiloke et al. reported that leaf extract induces apoptosis and 
increases oxidative stress (35). In another study by Purwal et al., 
tumorous mice were treated with methanol extract of leaves at 
concentration of 1 g/kg body weight of mice. The methanol extract of 
leaves is effective in delaying the tumor growth and increasing viable 
time of mice (36). 
The crude extract of M. oleifera leaves represents the inhibitory on 
subG1 phase, inducing apoptotic and some molecular targeting in 
different cancer cell lines (34, 35). However, the effects of M. oleifera 
leaves on molecular mechanism of cancer in human colon cancer cells 
have not been studied. Therefore, it is of interest to determine whether 
there are activities of M. oleifera leaves on colon cancer cells. First 
screening, we focused on the apoptosis study. 
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From our preliminary studies, the crude methanol extracts from 
seven parts of M. oleifera were prepared using Soxhlet Extractor and 
were evaluated the cytoxicity in HCT116, HT29 and HeLa cell lines. 
The results showed that the leaves, flowers and pods owned the highest 
inhibitory effect on all cancer cells. However, the leaves extract was 
chosen for the further studies because of the limit content from the 
flowers and pods which could be harvested only in cool season in 
Thailand.  
The objective of this study, we examined the effects of the 
fractionated M. oleifera leaves extract and its active phenolic compound, 
kaempferol, on cell viability and apoptosis in HCT116 cells. Kaempferol 
constituent compound in M. oleifera leaves is found to induce apoptosis 
in HCT116 cells (37). Moreover, to clarify the bioactive compound from 
M. oleifera leaves we isolated as well as identified phytochemical 
compounds from the bioactive fractions that may be responsible for the 
anti-colon cancer activity. The knowledge gained from this research is to 
ensure the M. oleifera leaves can be ulitized as an alternative or 
protective anti-colon cancer agent and may expand knowledge of 
medicinal herb use instead of chemical medicine. 
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MATERIALS AND METHODS  
 
Chemicals and antibodies 
1. Sephadex LH-20 (GE Healthcare, Waukesha, WI, USA) 
2. Silica gel PSQ 100B(Fuji Sylisia, Kasugai, Japan)  
3. ODS Chromatorex (Fuji Sylisia, Kasugai, Japan)  
4. ODS RP18 F254 TLC plates (Merck, Germany) 
5. Dulbecco's Modified Eagle Medium (D-MEM) (Life Technologies, 
Gaithersburg, MD, USA) 
6. 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT)  
(Dojindo Molecular Technologies, Kumamoto, Japan) 
7. Adriamycin (ADR) (Sigma, St. Louis, MO, USA)  
8. Kaempferol (Sigma, St. Louis, MO, USA) 
9. Anti-cleaved caspase-3 antibody (Cell Signaling Technology, Beverly, 
MA, USA) 
10. Alexa Fluor 647-labeled IgG secondary antibody (Life Technologies) 
11. Prolong AntifadeTM reagent (Life Technologies) 
 
Methods 
1. Plant material collection and extraction 
Fresh leaves of M. oleifera were harvested from Thailand. The fresh 
leaves were washed and dried. The dried leaves were blended and extracted in 
100% methanol using a Soxhlet Extractor. The crude extracts were dried using an 
evaporator and stored at 4°C with protection from light. 
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2. Fractionation on gel filtration chromatography 
The crude extract from M. oleifera leaves was dissolved in 70% (v/v) 
EtOH at 0.5 g/ml. Crude extract solution was filtered through 0.45-µm pore filter 
membranes (Merck Millipore, Bedford, MA, USA). The crude extract solution was 
then fractionated using a column A (Fig. 1). The eluate was collected at 5 ml per 
fraction and determined at UV 210 and 260 nm (38-40) using a SmartSpecTM 3000 
spectrophotometer (Bio-Rad). The fractions were collected until the reading at 210 
and 260 nm was not detected. Finally, the aqueous fractions were dried and stored 
at -20°C with shielding from light.  
 
3. Biological Assays 
3.1 Cell viability 
MTT method was used to measure the effect of the extract from M. 
oleifera leaves on cell viability.  In brief, human HCT116 colon cells were 
seeded at a density of 5 x 103 cells per well in a 96-well plate and incubated 
overnight at 37°C before treatment. The cells were maintained D-MEM 
containing 10% inactivated fetal bovine serum (FBS). The pooled fractions 
were dissolved in dimethyl sulfoxide (DMSO); its final concentration never 
exceeded 0.5% (v/v) DMSO in each concentration. After a period of cell 
incubation, various dilutions of pooled fractions (pf1, pf2, pf3, and pf4) were 
added to the prepared plate, compared with ADR (0.5 µg/ml) and kaempferol 
as positive controls and 0.5% DMSO as a negative control. The plates were 
further incubated for 24 or 48 h in triplicate cultures and were then washed 
with phosphate-buffered saline (PBS) and replaced with 1 mg/ml MTT 
solution for 4 h. At last, MTT solution was removed and was added 100 µl 
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DMSO. The colored products were measured the absorbance at 595 nm. Cell 
viability (%) of each condition was calculated as previously described (10). 
 
3.2 Double staining for cleaved caspase-3 and propidium iodide 
1.0 x 104 cells were seeded in 96-well plates and cultured in D-MEM 
containing 10% FBS for 24 h. Cells treated with the each sample for 24 h. 
Cells inducing apoptosis were performed by labeling cells with cleaved 
caspase-3 antibody and propidium iodide (PI) and analyzed as described 
Kubota et al (41). Cells were trypsinized, fixed in 4% paraformaldehyde for 
30 min, and permeabilized with ice-cold 70% ethanol for 1 h. Cells were 
washed in PBS containing 0.1% Tween 20 and added with anti-cleaved 
caspase-3 antibody. The reaction was incubated for 1 h at room temperature. 
Next, cells were stained with Alexa Fluor 647-conjugated anti-rabbit IgG 
antibody for 1 h. After that, DNA staining using 200 µg/ml RNase A and 50 
µg/ml PI was added at 37°C for 30 min. Representative cells was assessed 
after treating and was analyzed by flow cytometry. Data were analyzed using 
Flowing Software version 2.5.1 (Perttu Terho, Centre for Biotechnology, 
Turku, Finland).  
 
4. Isolation and purification 
The bioactive fractions, pf2 and pf3 were resuspended in MeOH and then 
subjected to ODS (octadecylsilyl) column with different mobile phase. The pf 2 
was eluted with a gradient mixture of 30-100% methanol in H2O using a 2.0 x 21.5 
cm column while the pf3 was eluted with a gradient mixture of 30-100% methanol 
in H2O using a 1.7 x 21.6 cm column. Note that, the pf2 and pf3 were used for 
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isolation and purification step that provided from previously study. So the amount 
of each pooled fraction was not directly from fractionation step. 
The dried pf2 (40 mg) was eluted, collected and then analyzed by TLC, 
yielding 38 fractions which were pooled into sixteen fractions (f1-f16) based on the 
TLC patterns.  The fraction f6, a yellow color spot on TLC, was concentrated using 
a rotary evaporator, yielding approximately 2.6 mg of dried extract. The f6 (2.6 
mg) was further separated by gel filtration, a 2.0 x 35 cm Sephadex LH-20 column, 
eluted with 80% methanol and then analyzed by thin layer chromatography (TLC). 
Based on the TLC patterns, the eluted subfractions were combined into seventeen 
subfractions (sf1- sf17). The sf13 (0.9 mg, compound A) was further subjected to 
identify using 1H NMR and MS. 
The dried pf3 (10 mg) was subjected to ODS column and eluted with 
similar procedures. The collected eluates were monitored by using Thin-layer 
chromatography (TLC) to obtain 29 fractions (F1-F29). The F9 (1 mg, compound 
B) with a yellow color spot on TLC was further subjected to identify using 1H 
NMR. The isolated pure compounds were identified by comparing their 1H NMR 
and MS with published data. 
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Fig. 1. Separation scheme (the active fractions are bolded). 
 
5. General experimental procedure 
5.1 Analytical thin-layer chromatography (TLC) 
TLC was done with glass pre-coated ODS RP18 F254 plates, 
developing with gradient methanol-H2O (40:60-80:20). Spots were 
visualized both under UV irradiation at 254 and 365 nm and by spraying 
with 50% H2SO4, then, the plate was heated at 90–100 °C at least 2-3 min.  
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5.2 Open column chromatography 
Column A 
Column size:  2.5 cm diameters, 37.5 cm length 
Adsorbent:  Sephadex LH20 
Solvent:   70% ethanol 
Column B 
Column size:  2.0 cm diameters, 21.5 cm length 
Adsorbent:  ODS Chromatorex 
Solvent:   Gradient mixture of 30-100% methanol in H2O and  
100% methanol with 0.1%TFA  
Column C 
Column size:  2.0 cm diameters, 35.0 cm length 
Adsorbent:  Sephadex LH20 
Solvent:   80% ethanol 
Column D 
Column size:  1.7 cm diameters, 21.6 cm length 
Adsorbent:  ODS Chromatorex 
Solvent:   Gradient mixture of 30-100% methanol in H2O  
    and 100% methanol with 0.1%TFA  
 
5.3 Instruments for determination of compounds 
Mass Spectra (MS) was measured on a JEOL AccuTOF-T100LP 
spectrometer (JEOL, Tokyo, Japan). 1H Nuclear Magnetic Resonance 
(NMR) spectra were recorded on an ECA 600 spectrometer (JEOL, Tokyo, 
Japan) with deuterated solvent.  
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6. Statistical analysis 
The results are presented as means ± SD (standard deviation) of three 
experiments. The statistical significance of the results was evaluated by two-way T-
test. The p-values (probability values) less than 0.05 or 0.005 was considered to be 
significant.  
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RESULTS 
 
Fractionation on gel filtration chromatography  
The chromatograms of the eluates detection by UV spectrophotometer and a 
recorder were shown in Fig. 2. The chromatograms showed several fractions and 
several inner peaks from the M. oleifera leave extracts. The fractionation of M. 
oleifera leaves was divided into four groups (pf1-pf4) according to their absorbance 
at 210 and 260 nm.  As it was indicated as the number 1 to 4, it meant to those four 
groups of fraction, pf1 to pf4, respectively.  Moreover, they, pf1 to pf4, were found 
to contain a high, intermediate, small and smallest amount of yield, respectively. 
Each pooled fractions were further evaluated for biological activities. 
 
 
 
Fig. 2. Chromatograms of the extracts from M. oleifera leaves. Fractions were collected using 
425 ml of 70% EtOH as an eluent. A whole leaf extract at the weight of 0.5 g was applied onto 
the column packed with Sephadex LH-20. Collected fractions were measured at OD 210 and 260 
nm, giving a yield of four pooled fractions, 1-4.  
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Biological assays 
1. Cell viability          
A primary screening for antitumor activity was carried out with MTT method 
by using the four pooled fractions (pf1-pf4). Due to limited quantities of the 
fractions, only three pooled fractions (pf1-pf3) from M. oleifera leaves extract were 
investigated for their biological activities. It was found that pooled fractions 
showed a relatively high antiproliferative activity in HCT116 cells. Firstly, they 
were examined the antiproliferative activity by MTT reduction assay in colon 
cancer, HCT116, cells. Studies on cell viability of HCT116 cells with and without 
the addition of three pooled fractions are illustrated in Fig. 3, using ADR as a 
positive control and 0.5% (v/v) DMSO as a negative control. The pf1, pf2 and pf3 
showed anti-proliferative effects in a dose-dependent manner during 24 and 48 h 
(Fig. 3A and 4B). When cells were incubated for 24 h, pf2 and pf3 were observed 
to be significantly more cytotoxic than pf1. It suggests that the components present 
in pf2 and pf3 are more effective than those in pf1. In addition, slightly decrease of 
viability in the HCT116 cells was observed in the treatment of kaempferol (Fig. 4). 
HCT116 cells were least affected by kaempferol, compared to the pooled fractions. 
From all of the above data, the pf2 and pf3 were very potent in reducing growth of 
HCT116 cells. 
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Fig. 3. Effects of each pooled fraction (pf1-pf3) on the growth of HCT116 cells. 
Cells were treated with indicated concentration of each pooled fraction. Cells were 
continuous exposed to the pooled fractions or controls at 24 h (A) or 48 h (B). Each 
value is the mean ± SD of triplicate of cultures.  
A 
B 
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Fig. 4. Effect of kaempferol on the growth of HCT116 cells. Cells were treated 
with indicated concentration of kaempferol for 24 and 48 h. Each value is the mean 
± SD of triplicate of cultures.  
 
2. Apoptosis analysis 
To further verify into the nature of growth inhibition by pooled fractions, 
FACS analysis was performed. To distinguish the live cell from dead population 
and demonstrate the apoptosis induced by pooled fractions from M. oleifera leaf 
was observed by anti-cleaved caspase-3 antibody and propidium iodide (PI) double 
staining method. After 24 h treatment of ADR (1.0 µg/ml), kaempferol (100 µM), 
or 0.25 µg/ml of pf1~pf3, the percentage of cells undergoing apoptosis in the 
HCT116 cells is presented in Fig. 5. The results showed that pf1 and pf2 cause a 
significant increase of 83.0% and 20.9% caspase-3 positive cells (as an apoptotic 
cells), respectively. Notably, pf1 treatment can induce the largest level of cleaved 
caspase-3-positive cells, compared with other pooled fractions. Even though 
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kaempferol treatment showed significantly increased cleaved caspase-3-positive 
cells, the treatment with pooled fractions was able to induce more cleaved caspase-
3-positive cells than that with kaempferol.  
       
 
 
Fig. 5.  Apoptosis was quantitated as the percentage of cleaved caspase-3-positive 
cells. Values are mean ± SD of three independent experiments. *P<0.05, 
***P<0.005, significantly different from the negative control as treatment with 
0.5% of DMSO (vehicle).  
 
 
Isolation and Purification 
   To clarify phytochemical components in the bioactive pf2 and pf3 fraction 
from methanol M. oleifera leaves extract, those two fractions were therefore 
selected further isolation and identification analysis. 
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By TLC analysis, either compound A or B was separated on ODS plate, 
using MeOH: H2O (60:40) as a mobile phase, and sprayed with 50% H2SO4 and 
charred at 90-100 °C. Those were revealed the presence of yellow spot at Rf of 
0.393 and 0.464, respectively (Fig. 6). Then, compound A and B were subjected 
further to the optimized preparative column chromatography. 
 
 
Fig. 6. TLC plate of pf2 and pf3 
 
The structures elucidation of isolated compounds were determined from their 
MS and 1H NMR spectral data, and compared with the literatures. The 1H NMR 
spectra of A and B showed the characteristic signals of flavonoid glycosides. The 
molecular formula of A and B were indicated as C21H20O11 and C21H20O12, 
respectively by MS, which gave molecular ion peak at m/z 447 and 463 [M-H] -. In 
addition to the compound A and B mass and 1H NMR spectra showed signals 
corresponding to a sugar moiety. Thus, the structure of A and B was determined as 
kaempferol 3-o-glucoside (astragalin) and quercetrin 3-o-glucoside (isoquercetin), 
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respectively (Fig. 7). However, there are others compound also contained in the pf2 
and pf3 that represent in the TLC spots. 
 
Astragalin: yellow amorphous powder, Molecular formula: C21H20O11. LC-MS: 
m/z 447 [M-H]-. 1H NMR (600 MHz, CD3OD): δ ppm 7.92 (d, J=8.8, 2H, H-2ʹ, 6ʹ), 
6.75 (d, J=8.8, 2H, H-3ʹ, 5ʹ), 6.21 (d, J=2.1, 1H, H-8), 6.03 (d, 2.1, 1H, H-6), 5.08 
(d, J=7.2, 1H, H-1ʺ of Glc). (45) 
Isoquercetin: yellow amorphous powder, Molecular formula: C21H20O12, LC-MS: 
m/z 463 [M-H]-. 1H NMR (600 MHz, CD3OD) δ ppm 7.70 (d, J=2.3, 1H, H-2ʹ), 
7.58 (dd, J=2.3, 8.5, 1H, H-6ʹ), 6.86 (d, J=8.5, 1H, H-5ʹ), 6.35 (d, J= 2.1, 1H, H-8), 
6.17 (d, J=2.1, 1H, H-6), 5.23 (d, J=7.7, 1H, H-1ʺ of Glc). The peaks assigned in 
1H NMR corresponded to those Refs. (46) 
 
           
 
Fig. 7.  Structure identification of compound A and B isolated from the active 
ethanol fraction (pf2, pf3) 
 
 
 
 
 
Astragalin Isoquercetin 
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DISCUSSION 
In the present study, we extract M. oleifera leaves with 100% methanol at 
50-60°C by using Soxhlet extractor. It has been reported that the Soxhlet extraction 
technique is a good extraction method giving a high recovery yield of extract. 
Moreover, this method offers good recovery of bioactive constituents which are 
thermostable compounds (47). Various solvents have been used in the extraction 
process of M. oleifera leaves. When M. oleifera leaves are extracted by shaking and 
reflux method with either methanol or ethanol, there is a little difference in total 
phenolic and flavonoid content of extracts (48). The various extraction methods 
have been studies for determination of major constituents of leaf, total phenolic and 
total flavonoid content, including maceration, percolation and Soxhlet extraction 
method. When 70% ethanol is used as the solvent of extraction, maceration method 
gives the highest total phenolic and flavonoid content, follows by Soxhlet 
extraction and percolation. However, the Soxhlet extraction provides the highest 
antioxidant activity using DPPH assay, compared to maceration (49). 
To fractionate the components in the extracts from M. oleifera leaves, we 
perform a Sephadex LH-20 column chromatography. This separation method is 
based on differences in the size of the molecules and widely used for isolation of 
small molecules from plant natural products (50). In this study, the results shows 
that the components from early collected are the large molecules that larger than 
the largest pores of the swollen beads (above the exclusion limit). Those are not 
able to penetrate into the gel beads and therefore, pass through the bed in the 70% 
ethanol phase and elute from the column first, follow by smaller molecules. Note 
that, the elution step using 70% ethanol should remove all components that have 
been retained on the column. The entire separation process takes place using 425 
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ml (2.3 times of one total column volume) of solvent passing through the Sephadex 
LH-20 column to remove all expected components. The limitation of this 
fractionation is that each collected fraction yield is very small and not usable in 
further biological assays. Thus, each collected fraction is combined into 4 pooled 
fractions (pf1, pf2, pf3 and pf4), based on their chromatogram pattern at OD 210 
and 260 nm (Fig 3). The pf1 is weighted and give the largest amount, comparing 
with other pooled fractions. Each pooled fraction has the components related in size 
of molecule. For example, components in pf1 have larger size molecules than that 
in pf2, pf3 and pf4, respectively. Due to the tiny yield (less than 1 mg) of last 
pooled fraction (pf4), it is unable to evaluate for the cell proliferation assays. Low 
amounts of active compounds are frequently obtained from a plant extract (51). To 
assess extensive biological studies, it needs to have larger amounts of active 
compounds. This generally involves the need for a re-fractionation of the M. 
oleifera leaves extract, which should be performed in the scale up of fractionation 
system. 
When HCT116 cells are carried out for determining the proliferation, pf2 and 
pf3 are able to reduce cell growth more than pf1. Our results may suggest that 
components in pf2 or pf3, which are smaller molecules than that found in pf1, have 
the inhibitory effect on HCT116 cell proliferation and having a greater effect than 
that in pf1. On the contrary, pf3 is not able to demonstrate clear inhibition of 
apoptosis, it exhibits a strong inhibitory activity on cell growth. The pf1 represents 
the strongest induction of apoptotic effect. Comparing with the kaempferol, each 
pooled fraction obtains the strong anti-proliferative effect and apoptotic induction 
effect. In the previous studies, the ethanol extract of M. oleifera leaves gives 
various phytochemicals, such as glucosinolates, flavonoids, and phenolic acid (52). 
Seeram and coworkers (2015) have reported that pomegranate juice is more potent 
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than its individual ingredients (punicalagin, ellagitannin and ellagic acid) on human 
colon (HT29, HCT116, SW480, SW620), prostate (RWPE-1, 22Rvl) and oral (KB, 
CAL27) tumor cells. It is also indicated that the synergistic and/or additive effects 
from the other components presenting in pomegranate juice are antioxidant and 
antiproliferative activities (53). Accordingly, among the three pooled fractions, 
pf1~pf3, from M. oleifera leave extracts, each pooled fraction has many small 
molecules of components. Those components may synergistically increase the 
effects of antiproliferation and apoptosis induction on HCT116 cells, comparing to 
the individual component, kaempferol. From all of the above data, it can be 
concluded that HCT116 cell growth are effectively inhibited and its apoptosis is 
generally induced induced by pooled fractions. This may partially result from the 
different components that contain in each pooled fraction. However, to use M. 
oleifera as the anticancer of colon, the further study is needed especially on the 
molecular signaling mechanism. 
It should be noted that pf1 is not chosen for the isolation study. Since pf1 is 
eluted firstly from the column, it may contain a large amounts of various impurities, 
for instance, fatty acids, chlorophylls and other large molecules.	 These large 
molecules may interfere the activities of biological components.	 Normally, the 
bioactive compounds are a small molecule (54).	For this reason, the pf2 and pf3 are 
selected to identify the major components. Actually, Sephadex LH-20 is a gel 
filtration matrix that able to remove large molecules of contaminants, yielding  
small biomolecules in a single step (54). 
From the gel filtration chromatogram, it is found that some molecule may 
bind non-specifically to Sephadex LH-20 gel. Since the component obtained from 
pf2 and pf3 is astragalin and isoquercetin, respectively but the molecular weight of 
astragalin and isoquercetin is 448.37 and 464.4, respectively. Thus, some 
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components from pf2 and pf3 are not always eluted by size exclusion. This may be 
due to the weak bond interaction, hydrophobic or hydrophilic interaction, between 
those molecules and gel matrix in the chromatography column. 
It is not surprising that astragalin and isoquercetin were obtained from M. 
oleifera leaves as it showed in previous studies (55). Astragalin and isoquercetin 
are a flavonoid glycoside and are obtained from other leaves such as Diospyros 
kaki leaves, mulberry leaves, Sapium sebiferum leaves (56-59). Many studies of 
astragalin and isoquercetin have focused on in vitro antioxidant activity and are not 
directly applicable to the endpoint of human colon cancer prevention (60, 61). 
Since active pooled fractions (pf2, pf3) are strong potent inhibitor of HCT116 cell 
growth. The isolated compounds (astragain, isoquercetin) were also obtained from 
our work, biological studies should be performed to find whether isolated 
compounds may be capable to inhibit colon cancer cells growth. There is still much 
work needed to search for novel and effective anticancer aiming on small 
compounds to further reveal in colon cancer prevention. 
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